Medicine
Clinical Impact of Plasma TGF-β1 and Circulating TGF-β1 mRNA in Diagnosis of Hepatocellular Carcinoma
Z. Dong, Dengfu Yao, M. Yao, L. Qiu, Lei Zong, Wei Wu, Xin-hua Wu, D. Yao, Xian-yong Meng
tlooto Summary
Abnormal expression of hepatic TGF-beta1 is associated with the degree of HCC differentiation and HBV replication, and both circulating TGFs can be used as sensitive biomarkers for the diagnosis and prognosis of HBV-induced HCC.
Abstract
Abstract is not available.
Citation format
DONG, Z., et al. Clinical impact of plasma TGF-β1 and circulating TGF-β1 mrna in diagnosis of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International, 2008, 7: 288–295.